Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Omadacycline tosylate by Paratek Pharmaceuticals for Mycobacterium Infections: Likelihood of Approval
Omadacycline tosylate is under clinical development by Paratek Pharmaceuticals and currently in Phase II for Mycobacterium Infections. According to GlobalData,...